The aim of the AMCP Format is to identify comprehensive evidence and information elements that meet the evidentiary needs of HCDMs. The AMCP Format is designed to encourage sharing of objective, credible, and relevant information on medical products.
FormularyDecisions® is an online platform that provides US healthcare decision-makers (HCDMs) with connections to peer insights, access to evidence-based resources, and bi-directional communication with biopharma companies. AMCP pre-approval information exchange (PIE) webinars, digitized dossiers, comprehensive product summaries, and biosimilars information, along with other tools are available exclusively through FormularyDecisions.
Where We Stand: AMCP opposes statutory and regulatory proposals that unduly restrict the ability of pharmacists working within managed care organizations from utilizing tools and services that are essential for the management of a prescription drug benefitFind out about Regulation of the Prescription Drug Benefit.
Sponsored webinar that covers an analysis performed by Optum Insight and provides actionable intelligence to guide formulary decision making in the nasal polyp treatment category.
AMCP Webinar that discussed nuances between HEOR and HCEI, payer HCEI needs and associated implications, current manufacturer practices for HCEI communications, and pathways that compliantly enhance the opportunity for information exchange.
